SCHEMBL2290423

SCHEMBL2290423

Cc1cccc(C)c1OCc1cc(OC(=O)c2ccccc2)c(OC(=O)c2ccccc2)cc1C=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.39
MAPT P10636 6/20 0.39
MEN1 O00255 5/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 3/20 0.39
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39
POLB P06746 1/20 0.39
JAK2 O60674 1/20 0.39
USP2 O75604 1/20 0.39
GAA P10253 1/20 0.39
ALOX15 P16050 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTGER4 P35408 2/20 0.38
PTGER3 P43115 2/20 0.38
PTGER2 P43116 2/20 0.38
CYP3A4 P08684 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL2293259 0.87 PTPN1 (0.47) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
SCHEMBL2292761 0.85 PTPN1 (0.48) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
SCHEMBL1201013 0.85 KMT2A (0.47) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
SCHEMBL2293253 0.84 SMN1; SMN2 (0.55) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
SCHEMBL2295218 0.83 THRA (0.46) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
SCHEMBL2295286 0.80 ALDH1A1 (0.46) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
SCHEMBL2290946 0.77 CDK4 (0.39) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
SCHEMBL2289128 0.77 ALDH1A1 (0.37) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
SCHEMBL2286452 0.75 ALDH1A1 (0.36) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1
Benzene SCHEMBL2292646 0.75 KDM4E (0.43) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2149545-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2016-10-05 EP disclosed
US-7994367-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-09 US disclosed
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 US disclosed
EP-2149545-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, C9, TRPA1 KMT2A 481/4885MAPT 3284/4885MEN1 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.